We herein describe the second case in the literature of an adult with a deep GA confined to the orbit. We could not identify any potential etiology from the patient’s history, and neither recurrence nor additional lesions have been noted after 2 years of follow-up.

A 32-year-old black woman came to our attention due to dissatisfaction with the cosmetic appearance of her blind left eye, with exotropia and leukocoria, interfering with her professional, social and personal life. At the slit lamp, we found a clear cornea, a quiet anterior chamber, a normal iris and a white pupillary refl ex due to white cataract and fi brotic retinal detachment. An Artisan® pupil occluder was enclavated retropupillary, keeping the cataract intact. Strabismus was surgically corrected. Despite the uneventful immediate post-operative course, two weeks after surgery, patient presented with posterior dislocation of the pupil occluder by release of one of the haptics, inducing cataract subluxation. Intracapsular cataract extraction was performed and the pupil occluder was repositioned anterior to the iris. At one year follow-up, the eye remains quiet. Exotropia was corrected and the pupil occluder is well centered with an excellent cosmetic appearance. Patient is extremely satisfi ed with the outcome.

We describe the treatment of lower eyelid cicatricial ectropion in a 24-year-old male using volumizing hyaluronic acid (HA) filler. One milliliter of Juvéderm Voluma® (Allergan) was injected directly under the skin in each lower eyelid to create a large bubble. The filler was dissolved with hyaluronidase (750 I.U. / side) 5 months later, achieving an excellent and stable functional and cosmetic result. There was a 2.4 mm improvement in MRD-2 with the filler in place, which decreased to 1.72 mm at 6 months after filler dissolution with hyaluronidase. This resulted in complete resolution of the signs and symptoms of corneal exposure. To date, there have been reports of low density HA injection for the treatment of cicatricial ectropion in elderly patients as well as infants with lamellar ichthyosis. In these cases, the HA was injected and left in place to dissolve spontaneously by itself. Our case is the first report of a HA with high G properties injected directly under the skin, followed by complete dissolution with hyaluronidase once the tissue expansion took place.

Purpose: To describe the characteristics of the OBL and its possible relationship with flap and laser parameters. Study Design: Observational, descriptive and transversal investigation. Method: The study was performed on 76 patients undergoing FemtoLASIK with refractive suite WaveLight FS 200 and EX500 Excimer Laser (Alcon) from September to December 2016. Analyzed flap and laser variables, through absolute and relative frequencies, and odds ratio to identify factors that could increase the likelihood of OBL. Results: OBL was present in 15.8% of the cases, with a predominance (83.3%) of late OBL. A greater probability of OBL was obtained in patients with flap diameter of 8.0 mm (OR = 8.4 p = 0.004), laser energies greater than 0.80 mJ (OR = 62 p <0.001), channel length of 0, 7 mm (OR = 5.7 p = 0.01), suction time greater than 50 s (OR = 8.3 p = 0.01). There is no greater probability of OBL for thinner flap thickness (OR = 0.2 p = 0.06) or higher temperature (OR = 2.0 p = 0.26) Conclusions: A low incidence of OBL was obtained. Late OBL was the most frequent. There is a greater probability of this complication in surgeries with ablation energies greater than 0.80 mJ, flap diameters of 8.0 mm, channel length of 0.7 mm and suction time greater than 50 seconds. Resumen Objetivo: Describir las características de la OBL y su posible relación con parámetros del flap y del láser. Diseño: Investigación observacional, descriptiva y transversal. Método: Se realizó un estudio en 76 pacientes intervenidos por FemtoLASIK con la suite refractiva WaveLight FS 200 y EX500 Excímer Láser (Alcon) de Septiembre a Diciembre del 2016. Se analizaron variables del flap y del láser, a través de frecuencias absolutas y relativas, y el odds radio para la identificación de factores que podrían aumentar la probabilidad de OBL. Resultados: Se obtuvo presencia de OBL en el 15,8 % de los casos, con predominio (83,3 %) de OBL tardía. Se obtuvo mayor probabilidad de OBL en pacientes con diámetro del flap de 8,0 mm (OR=8,4 p=0.004), energías del láser superiores a 0.80 mJ (OR=62 p<0,001), longitud del canal de 0,7 mm (OR=5,7 p=0,01), tiempo de succión superior a 50 s (OR=8,3 p=0,01). No existe mayor probabilidad de OBL por menor grosor del flap (OR=0,2 p=0,06) o mayor temperatura (OR=2,0 p=0,26). Conclusiones: Se obtuvo una baja incidencia de OBL. La OBL tardía fue la más frecuente. Existe mayor probabilidad de presencia de esta complicación en cirugías con energías de ablación superiores a 0,80 mJ; diámetros del flap de 8,0 mm; longitud del canal de 0,7 mm; tiempo de succión superior a 50 segundos.

Purpose: To describe the characteristics of myopic choroidal neovascular membranes of hispanic subjects treated with a loading dose of Ranibizumab (Lucentis®). Study design: Non-randomized prospective observational case study. Methods: Five eyes of 5 patients with naïve CNV secondary to pathological myopia were recruited for this study. Demographics, basal best-corrected visual acuity, grade of myopia, angiographic and tomographic features were obtained at baseline. A loading dose of three monthly Ranibizumab (Lucentis®) injections were given to the recruited subjects. After completion of the loading dose, a complete ophthalmological evaluation, angiography and spectral domain optical coherence tomography (SD-OCT) were obtained subsequently at six and twelve months of follow-up. Results: The mean age of patients was 45 years. The mean spherical equivalent refractive error was -13.85. At baseline, the mean number of letters was 61.4 and at follow-up to 12 months the mean number of letters was 73.2. The central foveal thickness and subfoveal choroidal thickness decreased in all cases. After loading dose there was no persistent nor recurrent leakage from treated CNV on fluorescein angiography. FAF evidenced an increase in the area of atrophy, with a special circle pattern around the CNV. Conclusions: This study showed a functional and morphologic improvement at 12 months in five Colombian subjects treated with a loading dose of 3 Ranibizumab monthly injections.

Purpose: To describe the results of selective laser trabeculoplasty for patients with open-angle glaucoma during a 2-year period. Study design: Descriptive, retrospective, and longitudinal study. Method: A descriptive, retrospective, and longitudinal study was conducted among 40 eyes of 20 patients who underwent selective laser trabeculoplasty from 2012 to 2015 and received topical antiglaucoma medication. The following variables were measured: uncorrected visual acuity, best-corrected visual acuity, and intraocular pressure before treatment and during monitoring controls after 1 day, 7 days, 1 month, 3 months, 6 months, 12 months, and 24 months. Results: No significant differences were identified between uncorrected visual acuity preoperatively and at 1 year (p=0.091) or between preoperative uncorrected visual acuity preoperatively and at 2 years (p=0.827). Best-corrected visual acuity preoperatively and at 1 year showed no statistical significance (p=0.125); however, best-corrected visual acuity preoperatively and at 2 years had statistical significance (p=0.007). Mean ± standard deviation of preoperative intraocular pressure at 2 years had decreased from 17.28±5.7 to 13.05±2.4 mm Hg (statistically significant; p=0.00) and the success rate was 75%. Although the mean ± standard deviation of preoperative for drug use at 2 years decreased from 1.90±1.1 to 1.65±1.3, no significant difference (p=0.058) was identified. No complications were identified. Conclusions: Selective laser trabeculoplasty is an effective and safe treatment that reduces intraocular pressure as well as the number of drugs required by patients with open-angle glaucoma.